Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone
作者： J Cortés-Herández , J Ordi-Ros , M Labrador , A Segarra , J L Tovar
DOI: 10.1191/0961203303LU340OA
关键词: Lupus nephritis 、 Clinical trial 、 Gastroenterology 、 Immunosuppression 、 Pharmacotherapy 、 Internal medicine 、 Immunology 、 Predictive value of tests 、 Medicine 、 Methylprednisolone 、 Prospective cohort study 、 Cyclophosphamide
摘要: … Diffuse proliferative lupus nephritis (LN) is the most severe form of renal disease and 5 – 25% of these patients progress to end-stage renal disease (ESRD) requiring maintenance …
sagepub.com
sci-hub.se 参考文章(38)
James E Balow, HOWARD A AUSTIN III, GEORGE C TSOKOS, TATIANA T ANTONOVYCH, ALFRED D STEINBERG, JOHN H KLIPPEL, Lupus Nephritis Annals of Internal Medicine. ,vol. 106, pp. 79- 94 ,(1987) , 10.7326/0003-4819-106-1-79
Howard A. Austin, Larry R. Muenz, Kathleen M. Joyce, Tatiana A. Antonovych, Margarita E. Kullick, John H. Klippel, John L. Decker, James E. Balow, Prognostic factors in lupus nephritis The American Journal of Medicine. ,vol. 75, pp. 382- 391 ,(1983) , 10.1016/0002-9343(83)90338-8
D T Felson, E M Ginzler, J J Anderson, J M Anthony, Hypertension increases the risk of renal deterioration in systemic lupus erythematosus. The Journal of Rheumatology. ,vol. 20, pp. 1694- 1700 ,(1993)
D.T. Boumpas, H.A. Austin, J.E. Balow, E.M. Vaughan, C.H. Yarboro, J.H. Klippel, A.D. Steinberg, Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis The Lancet. ,vol. 340, pp. 741- 745 ,(1992) , 10.1016/0140-6736(92)92292-N
Howard A. Austin, Larry R. Muenz, Kathleen M. Joyce, Tatiana T. Antonovych, James E. Balow, Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney International. ,vol. 25, pp. 689- 695 ,(1984) , 10.1038/KI.1984.75
Elena Ciruelo, Javier de la Cruz, Ignacio López, Juan J Gómez‐reino, None, Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide Arthritis & Rheumatism. ,vol. 39, pp. 2028- 2034 ,(1996) , 10.1002/ART.1780391212
Vinod K. Bansal, Judith A. Beto, Treatment of lupus nephritis: A meta-analysis of clinical trials American Journal of Kidney Diseases. ,vol. 29, pp. 193- 199 ,(1997) , 10.1016/S0272-6386(97)90029-9
John PA Ioannidis, Kyriaki A Boki, Maria E Katsorida, Alexandros A Drosos, Fotini N Skopouli, John N Boletis, Haralampos M Moutsopoulos, None, Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide Kidney International. ,vol. 57, pp. 258- 264 ,(2000) , 10.1046/J.1523-1755.2000.00832.X
C Ponticelli, G Moroni, Flares in lupus nephritis: Incidence, impact on renal survival and management Lupus. ,vol. 7, pp. 635- 638 ,(1998) , 10.1191/096120398678920776
Dimitrios T Boumpas, Howard A Austin, Barri J Fessler, James E Balow, John H Klippel, Michael D Lockshin, Systemic Lupus Erythematosus: Emerging Concepts: Part 1: Renal, Neuropsychiatric, Cardiovascular, Pulmonary, and Hematologic Disease Annals of Internal Medicine. ,vol. 122, pp. 940- 950 ,(1995) , 10.7326/0003-4819-122-12-199506150-00009